| Similar Articles |
|---|
 |
The Motley Fool
October 26, 2006
Jack Uldrich |
Symyx Homes In on the Right Mix New nanomaterials and customers could catalyze the stock of this high-throughput technology and research software company. Investors, this remains one of the better ways to play this sector.   |
Information Today
August 20, 2007
Robert E. Buntrock |
Elsevier to Sell MDL to Symyx Technologies Elsevier buys Beilstein. Elsevier integrates Beilstein into MDL DiscoveryGate. Elsevier sells MDL to Symyx, which had previously purchased IntelliChem and Synthematix. Elsevier keeps Beilstein. These are interesting times in the cheminformatics business. |
The Motley Fool
February 13, 2006
Stephen D. Simpson |
Symyx's Formula for Success: Wait The sizzle of this chemical research expediter is enticing, but be careful not to get burned -- this stock has been pretty volatile over time. |
Bio-IT World
August 15, 2005
Johan Bostrom |
Symyx System Automates R&D Bay-Area-based research company Symyx Technologies is sharing lessons learned from its experience with lab automation by licensing its software or collaborating with other R&D companies. |
The Motley Fool
October 27, 2005
W.D. Crotty |
One Word: Plastics Dow Chemical reports hearty sales growth for the third quarter. But there is a lot more for long-term investors to investigate. |
Information Today
April 10, 2014 |
MDL Adds Journals Fulfillment via advance System MDL will implement Order to Cash as a way to expand into the journals fulfillment market, giving publishers subscription-based models for digital and print content and readers a seamless purchasing experience. |
